Syncona Limited

BACT

GG00B8P59C08

Investment Holding Companies

Market Closed - London S.E. Other stock markets 11:35:29 2024-07-05 am EDT			5-day change	1st Jan Change
117 ^GBX	+3.36%		+7.54%	-5.19%

Jul. 03	Syncona Invests Additional $42.5 Million in Beacon Therapeutics	MT
Jul. 03	Syncona's portfolio Beacon Therapeutics raises USD170 million	AN

Syncona Announces Resignation of Peter Hames as Non-Executive Director

September 08, 2017 at 11:39 am EDT

Syncona announced the resignation of Peter Hames as a non-executive director of the company, effective as of the completion of the company's Annual General Meeting, 8 September 2017.

Latest news about Syncona Limited

Syncona Invests Additional $42.5 Million in Beacon Therapeutics	Jul. 03	MT
Syncona's portfolio Beacon Therapeutics raises USD170 million	Jul. 03	AN
Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors	Jul. 02	CI
Syncona Chair & CEO Hollowood buys GBP100,000 in shares	Jun. 25	AN
Syncona Invests in Two Oncology Companies	Jun. 20	MT
Syncona swings to annual profit despite challenging market conditions	Jun. 20	AN
Transcript : Syncona Limited, 2024 Earnings Call, Jun 20, 2024	Jun. 20
Syncona Posts Swings to Profit for FY24; Total Investment Income Rises	Jun. 20	MT
Syncona Adds Ionctura And Yellowstone Biosciences To Its Portfolio	Jun. 20	RE
Tranche Update on Syncona Limited's Equity Buyback Plan announced on September 29, 2023.	Jun. 20	CI
Syncona Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Jun. 19	CI
Syncona’s Freeline, SwanBio Combine to Form Spur Therapeutics	Jun. 17	MT
Syncona to invest GBP40 million into newly created Spur Therapeutics	Jun. 17	AN
Syncona notes Autolus's first quarter loss widens amid higher costs	May. 17	AN
Syncona's Freeline gets positive results for Gaucher disease	May. 09	AN
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	May. 03	AN
Syncona agrees to sell stake in investee company for GBP7.4 million	Apr. 11	AN
Syncona to Sell Stake in Portfolio Company to Century Therapeutics	Apr. 11	MT
Syncona notes investee Achilles's annual loss narrows	Apr. 04	AN
Syncona portfolio company Autolus posts widened loss for 2023	Mar. 14	AN
Syncona’s Takeover of Freeline Therapeutics Becomes Effective	Feb. 20	MT
Freeline shareholders approve Syncona acquisition	Feb. 12	AN
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	Feb. 12	MT
Syncona portfolio strengthens in third quarter thanks to Autolus	Feb. 08	AN
Syncona's Fiscal Q3 NAV Declines	Feb. 08	MT

Syncona Limited is a Guernsey-based closed-ended investment company. The Companyâs investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.

Sector

Investment Holding Companies

Calendar

2024-08-06 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.17 GBP

Average target price

2.347 GBP

Spread / Average Target

+100.57%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Holding Companies

	1st Jan change	Capi.
SYNCONA LIMITED	-5.19%	967M
INVESTOR AB	+24.10%	84.25B
INVESTMENT AB LATOUR	+11.67%	17.86B
KOÇ HOLDING	+61.85%	17.81B
AB INDUSTRIVÄRDEN	+7.94%	14.57B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+25.65%	12.85B
L E LUNDBERGFÖRETAGEN AB	-2.86%	12.6B
MERITZ FINANCIAL GROUP INC.	+41.12%	11.13B
HAL TRUST	-1.05%	11.01B
SK SQUARE CO., LTD.	+98.10%	10.07B

Other Holding Companies

Syncona Limited

Equities

BACT

GG00B8P59C08

Investment Holding Companies

Syncona Announces Resignation of Peter Hames as Non-Executive Director

Latest news about Syncona Limited

Chart Syncona Limited

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Holding Companies